Welcome to LookChem.com Sign In|Join Free
  • or

130-85-8

Post Buying Request

130-85-8 Suppliers

Recommended suppliersmore

Product FOB Price Min.Order Supply Ability Supplier
BLOOM TECH Pamoic acid CAS 130-85-8
Cas No: 130-85-8
USD $ 10.0-10.0 / Gram 1 Gram 3 Metric Ton/Month Shaanxi BLOOM TECH Co.,Ltd Contact Supplier
pamoic acid
Cas No: 130-85-8
No Data 1 Kilogram 10 Metric Ton/Month Suzhou Xiaoli Pharmatech Co., Ltd. Contact Supplier
Pamoic acidCAS NO.: 130-85-8
Cas No: 130-85-8
USD $ 4.0-4.0 / Gram 1 Gram 10000 Gram/Day Henan Wentao Chemical Product Co., Ltd. Contact Supplier
High quality Pamoic Acid supplier in China
Cas No: 130-85-8
No Data No Data Metric Ton/Day Simagchem Corporation Contact Supplier
TNJ Pamoic Acid
Cas No: 130-85-8
No Data 25 Kilogram 1000 Metric Ton/Year Hefei TNJ chemical industry co.,ltd Contact Supplier
Factory Supply 3,3'-dihydroxy-4,4'-methylenedi(2-naphthoic acid)
Cas No: 130-85-8
No Data 1 1 Ality Chemical Corporation Contact Supplier
4-[(3-carboxylato-2-hydroxy-1-naphthalenyl)methyl]-3-hydroxy-2-naphthalenecarboxylate
Cas No: 130-85-8
No Data 10 Milligram Amadis Chemical Co., Ltd. Contact Supplier
Pamoic acid
Cas No: 130-85-8
No Data No Data No Data Chemwill Asia Co., Ltd. Contact Supplier
Pamoic acid
Cas No: 130-85-8
USD $ 3.0-3.0 / Kilogram 1 Kilogram 1-10 Metric Ton/Month Dayang Chem (Hangzhou) Co.,Ltd. Contact Supplier
Pamoic acid
Cas No: 130-85-8
USD $ 1.0-1.0 / Kilogram 1 Kilogram 2000 Metric Ton/Year Henan Sinotech Import&Export Corporation Contact Supplier

130-85-8 Usage

Safety Profile

Poison by intraperitoneal route. An eye irritant. When heated to decomposition it emits acrid smoke and irritating fumes.

Chemical Properties

Pamoic acid is yellow to yellow-green crystalline powder

Uses

Agonist of the orphan G protein-coupled receptor GPR35: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Used as an inhibitor in the real-time fluorescence enzymatic characterization study of specialized human DNA polymerases.
InChI:InChI=1/C23H16O6/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-10,24-25H,11H2,(H,26,27)(H,28,29)/p-2

130-85-8 Well-known Company Product Price

Brand (Code)Product description CAS number Packaging Price Detail
Alfa Aesar (A15207)  Pamoic acid, 99%    130-85-8 50g 422.0CNY Detail
Alfa Aesar (A15207)  Pamoic acid, 99%    130-85-8 250g 1009.0CNY Detail
Alfa Aesar (A15207)  Pamoic acid, 99%    130-85-8 1000g 2326.0CNY Detail
Sigma-Aldrich (PHR1407)  Pamoic Acid  pharmaceutical secondary standard; traceable to USP 130-85-8 PHR1407-1G 718.73CNY Detail
USP (1493000)  Pamoicacid  United States Pharmacopeia (USP) Reference Standard 130-85-8 1493000-250MG 4,588.74CNY Detail

130-85-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name pamoic acid

1.2 Other means of identification

Product number -
Other names Pamoic

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130-85-8 SDS

130-85-8Synthetic route

formaldehyd
50-00-0

formaldehyd

3-Hydroxy-2-naphthoic acid
92-70-6

3-Hydroxy-2-naphthoic acid

Pamoic acid
130-85-8

Pamoic acid

Conditions
ConditionsYield
With sulfuric acid In acetic acid for 10h; Heating;95%
With sodium hydroxide
With sulfuric acid; acetic acid
With sodium hydroxide
formaldehyd
50-00-0

formaldehyd

acetic acid
64-19-7

acetic acid

3-Hydroxy-2-naphthoic acid
92-70-6

3-Hydroxy-2-naphthoic acid

Pamoic acid
130-85-8

Pamoic acid

9-(3-Carboxy-2-hydroxy-naphthalen-1-ylmethyl)-2,4-dioxo-4H-1,3-dioxa-2λ5-phospha-anthracen-2-ol anion

9-(3-Carboxy-2-hydroxy-naphthalen-1-ylmethyl)-2,4-dioxo-4H-1,3-dioxa-2λ5-phospha-anthracen-2-ol anion

Pamoic acid
130-85-8

Pamoic acid

Conditions
ConditionsYield
With water at 40℃; Rate constant; var. pHs;
formaldehyd
50-00-0

formaldehyd

3-Hydroxy-2-naphthoic acid
92-70-6

3-Hydroxy-2-naphthoic acid

alkali

alkali

Pamoic acid
130-85-8

Pamoic acid

formaldehyd
50-00-0

formaldehyd

3-Hydroxy-2-naphthoic acid
92-70-6

3-Hydroxy-2-naphthoic acid

acid solution

acid solution

Pamoic acid
130-85-8

Pamoic acid

formaldehyd
50-00-0

formaldehyd

3-Hydroxy-2-naphthoic acid
92-70-6

3-Hydroxy-2-naphthoic acid

alkaline solution

alkaline solution

Pamoic acid
130-85-8

Pamoic acid

vortioxetine
508233-74-7

vortioxetine

Pamoic acid
130-85-8

Pamoic acid

vortioxetine semi pamoic acid salt

vortioxetine semi pamoic acid salt

Conditions
ConditionsYield
With acetic acid; sodium hydroxide In water at 20℃; for 2h;100%
Pamoic acid
130-85-8

Pamoic acid

bis(bupivacaine) pamoic acid

bis(bupivacaine) pamoic acid

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; Solvent;99.6%
In methanol; acetone Heating;39.6%
triethylamine
121-44-8

triethylamine

Pamoic acid
130-85-8

Pamoic acid

bis(triethylammonium) pamoate

bis(triethylammonium) pamoate

Conditions
ConditionsYield
In water for 1h; pH=~ 8.5 - 9;99%
pramipexole
104632-26-0

pramipexole

Pamoic acid
130-85-8

Pamoic acid

pramipexole pamoate

pramipexole pamoate

Conditions
ConditionsYield
In dimethyl sulfoxide; ethyl acetate at 20℃;99%
zyprexa
132539-06-1

zyprexa

Pamoic acid
130-85-8

Pamoic acid

olanzapine pamoate monohydrate

olanzapine pamoate monohydrate

Conditions
ConditionsYield
Stage #1: Pamoic acid With ammonium hydroxide In water
Stage #2: zyprexa With hydrogenchloride; water at 25 - 30℃; Reagent/catalyst;
97%
Stage #1: zyprexa; Pamoic acid In dimethyl sulfoxide at 20 - 25℃; for 0.333333h;
Stage #2: With water In dimethyl sulfoxide at 20 - 40℃; for 1.16667h;
impramine
50-49-7

impramine

Pamoic acid
130-85-8

Pamoic acid

imipramine pamoate

imipramine pamoate

Conditions
ConditionsYield
In ethyl acetate at 20 - 50℃; Solvent; Temperature;96%
Pamoic acid
130-85-8

Pamoic acid

mono(bupivacaine) pamoic acid

mono(bupivacaine) pamoic acid

Conditions
ConditionsYield
In methanol; acetone Heating;90%
In methanol; acetone90%
{(R)-2-[5-bromo-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester
830346-49-1

{(R)-2-[5-bromo-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester

Pamoic acid
130-85-8

Pamoic acid

(2-fluoro-3-methoxyphenyl)boronic acid
352303-67-4

(2-fluoro-3-methoxyphenyl)boronic acid

3-[2(R)-amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione pamoic acid salt

3-[2(R)-amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione pamoic acid salt

Conditions
ConditionsYield
Stage #1: {(R)-2-[5-bromo-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester; (2-fluoro-3-methoxyphenyl)boronic acid With sodium carbonate In 1,4-dioxane; water for 0.25h; Inert atmosphere;
Stage #2: With tetrakis(triphenylphosphine) palladium(0) In 1,4-dioxane; water at 95 - 100℃; Inert atmosphere;
Stage #3: Pamoic acid Further stages;
90%
7-amino-2,4-dimethyl-1,8-naphthyridine
39565-07-6

7-amino-2,4-dimethyl-1,8-naphthyridine

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

Pamoic acid
130-85-8

Pamoic acid

C10H11N3*C23H16O6*C3H7NO

C10H11N3*C23H16O6*C3H7NO

Conditions
ConditionsYield
In methanol at 20℃;88.23%
Galantamine hydrobromide
1953-04-4, 98125-73-6

Galantamine hydrobromide

Pamoic acid
130-85-8

Pamoic acid

galantamine bishydroxynaphthoate

galantamine bishydroxynaphthoate

Conditions
ConditionsYield
Stage #1: Galantamine hydrobromide With sodium hydroxide In ethanol for 0.5h;
Stage #2: Pamoic acid In dimethyl sulfoxide at 20℃; for 6h; Temperature; Solvent;
88.2%
In dimethyl sulfoxide at 25℃; for 6h; Solvent; Temperature;78.55%
1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-N-methylazetidin-3-amine

1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-N-methylazetidin-3-amine

Pamoic acid
130-85-8

Pamoic acid

1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-N-methylazetidin-3-amine 4,4'-methylenebis(3-hydroxy-2-naphthoic acid) salt

1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-N-methylazetidin-3-amine 4,4'-methylenebis(3-hydroxy-2-naphthoic acid) salt

Conditions
ConditionsYield
In ethanol at 20℃; for 20h;88%
(R)-(+)-tolterodine
124937-51-5

(R)-(+)-tolterodine

Pamoic acid
130-85-8

Pamoic acid

tolterodine palmoate

tolterodine palmoate

Conditions
ConditionsYield
In water at 20℃; for 4h; Temperature;87.27%
3-[2(R)-{3-cyanopropylamino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4-(1H,3H)-dione
832720-85-1

3-[2(R)-{3-cyanopropylamino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4-(1H,3H)-dione

Pamoic acid
130-85-8

Pamoic acid

C32H29F5N4O3*C23H16O6

C32H29F5N4O3*C23H16O6

Conditions
ConditionsYield
In methanol at 60 - 65℃; for 3h;87%
5-bromo-6-(imidazolin-2-ylamino)-quinoxaline
59803-98-4

5-bromo-6-(imidazolin-2-ylamino)-quinoxaline

Pamoic acid
130-85-8

Pamoic acid

brimonidine pamoate
1084892-10-3

brimonidine pamoate

Conditions
ConditionsYield
In ethanol; dimethyl sulfoxide at 20 - 65℃; Product distribution / selectivity;86%
In 1-methyl-pyrrolidin-2-one; water at 70℃; Product distribution / selectivity;
at 60 - 70℃; Product distribution / selectivity;
imipramine hydrochloride

imipramine hydrochloride

triethylamine
121-44-8

triethylamine

Pamoic acid
130-85-8

Pamoic acid

imipramine pamoate mono-triethylammonium salt
1357157-28-8

imipramine pamoate mono-triethylammonium salt

Conditions
ConditionsYield
In water for 3h;86%
benzyl bromide
100-39-0

benzyl bromide

Pamoic acid
130-85-8

Pamoic acid

C51H40O6
217327-71-4

C51H40O6

Conditions
ConditionsYield
With potassium carbonate85%
tapentadol
175591-23-8

tapentadol

Pamoic acid
130-85-8

Pamoic acid

tapentadol hemiembonate

tapentadol hemiembonate

Conditions
ConditionsYield
In ethanol for 1h;83.3%
4-methyl-1,3-benzothiazol-2-amine
1477-42-5

4-methyl-1,3-benzothiazol-2-amine

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

Pamoic acid
130-85-8

Pamoic acid

4C8H8N2S*2C23H16O6*4C3H7NO

4C8H8N2S*2C23H16O6*4C3H7NO

Conditions
ConditionsYield
In ethanol at 20℃;80.42%
Ropinirole
91374-21-9

Ropinirole

Pamoic acid
130-85-8

Pamoic acid

ropinirole pamoate

ropinirole pamoate

Conditions
ConditionsYield
In water; dimethyl sulfoxide at 20℃;80.4%
titanium(IV) isopropylate
546-68-9

titanium(IV) isopropylate

propan-1-ol
71-23-8

propan-1-ol

ethylenediamine
107-15-3

ethylenediamine

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

Pamoic acid
130-85-8

Pamoic acid

(Me2NH2)8[(Ti4(embonate)6)]·4(n-propanol)·2(ethylenediamine)·6(N,N-dimethylformamide)

(Me2NH2)8[(Ti4(embonate)6)]·4(n-propanol)·2(ethylenediamine)·6(N,N-dimethylformamide)

Conditions
ConditionsYield
at 100℃; for 72h; High pressure;78%
rotigotine
99755-59-6

rotigotine

Pamoic acid
130-85-8

Pamoic acid

rotigotine pamoate

rotigotine pamoate

Conditions
ConditionsYield
In water; dimethyl sulfoxide at 20℃;77.4%

130-85-8Downstream Products

130-85-8Related news

Development and evaluation of a 68Ga labeled Pamoic acid (cas 130-85-8) derivative for in vivo visualization of necrosis using positron emission tomography09/29/2019

In this study, we labeled N,N′-bis(diethylenetriamine pentaacetic acid)-pamoic acid bis-hydrazide (bis-DTPA-PA) with the generator produced PET radionuclide gallium-68 and evaluated 68 Ga-bis-DTPA-PA as a potential tracer for in vivo visualization of necrosis by positron emission tomogr...detailed

Construction of Two New Metal–Organic Frameworks from Pamoic acid (cas 130-85-8) and N-Containing Auxiliary Ligands09/28/2019

Two new metal–organic frameworks; namely, [Cd2(pam)2(bpe)1.5(DMF)2(H2O)] n ·2n(DMF) (1) and [Cd(pam)(bix)] n (2) (H2pam = pamoic acid, bpe = 1,2-di(4-pyridyl)ethylene, bix = 4,4′-bis(imidazol-1-ylmethyl)benzene, DMF = N,N′-dimethylformamide), were solvothermally synthesized via varying the ...detailed

Hydrothermal synthesis of tin-doped indium oxide nanoparticles using Pamoic acid (cas 130-85-8) as an organic additive and their photoluminescence properties10/01/2019

We report a facile hydrothermal method using the disodium salt of pamoic acid (Na2PA) as an organic additive, In(NO3)3·xH2O as an indium precursor, and SnCl2·2H2O as a tin precursor for preparation of ITO nanoparticles (NPs) at low temperature (200 °C). After drying at 110 °C, the as hydroth...detailed

Please post your buying leads,so that our qualified suppliers will soon contact you!

*Required Fields